Accéder au contenu
Merck

FiTAc-seq: fixed-tissue ChIP-seq for H3K27ac profiling and super-enhancer analysis of FFPE tissues.

Nature protocols (2020-06-28)
Alba Font-Tello, Nikolas Kesten, Yingtian Xie, Len Taing, Damir Varešlija, Leonie S Young, Anis A Hamid, Eliezer M Van Allen, Christopher J Sweeney, Evisa Gjini, Ana Lako, F Steven Hodi, Joaquim Bellmunt, Myles Brown, Paloma Cejas, Henry W Long
RÉSUMÉ

Fixed-tissue ChIP-seq for H3K27 acetylation (H3K27ac) profiling (FiTAc-seq) is an epigenetic method for profiling active enhancers and promoters in formalin-fixed, paraffin-embedded (FFPE) tissues. We previously developed a modified ChIP-seq protocol (FiT-seq) for chromatin profiling in FFPE. FiT-seq produces high-quality chromatin profiles particularly for methylated histone marks but is not optimized for H3K27ac profiling. FiTAc-seq is a modified protocol that replaces the proteinase K digestion applied in FiT-seq with extended heating at 65 °C in a higher concentration of detergent and a minimized sonication step, to produce robust genome-wide H3K27ac maps from clinical samples. FiTAc-seq generates high-quality enhancer landscapes and super-enhancer (SE) annotation in numerous archived FFPE samples from distinct tumor types. This approach will be of great interest for both basic and clinical researchers. The entire protocol from FFPE blocks to sequence-ready library can be accomplished within 4 d.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Butyrate de sodium, For use as a histone deacetylase inhibitor.
Roche
RNase, DNase-free, High Concentration, from bovine pancreas
Sigma-Aldrich
Anti-dimethyl-Histone H3 (Lys4) Antibody, Upstate®, from rabbit